Skip to content
  • Media
  • Investors
  • Media
  • Investors
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • For Physicians
    • Evidence
    • Resources
  • For Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Overview & Leadership
    • Board of Directors
    • Advisory Boards
  • Contact
  • Media
  • Investors
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • For Physicians
    • Evidence
    • Resources
  • For Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Overview & Leadership
    • Board of Directors
    • Advisory Boards
  • Contact
  • Media
  • Investors

Day: June 10, 2024

RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

RenovoRx announced today that Ryan Witt has joined the Company in the new role as Senior Vice President, Head of Corporate Strategy and Partnerships.

RenovoCath is FDA-cleared for targeted delivery of chemotherapy to selected sites in the peripheral vascular system. The company is studying the use of RenovoCath-delivered gemcitabine for treatment of Locally Advanced Pancreatic Cancer (LAPC) in an ongoing clinical trial conducted under an IND.

Facebook-f X-twitter Linkedin-in Youtube

Menu

  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • 2570 W. El Camino Real, Suite 640
    Mountain View, CA 94040
  • (650) 284-4433
  • info@renovorx.com
© 2026 RenovoRx®. All rights reserved.

Privacy Statement | Terms of Use